Annual reports and work programmes

The European Medicines Agency (EMA) publishes a full work programme and annual report, to provide an overview of the work of the Agency together with the European medicines regulatory network.

2021 annual reportEMA annual report 2021

EMA's 2021 annual report highlights the Agency's most significant achievements in 2021.

This includes EMA's core regulatory activities to protect public and animal health in the EU, and the European medicines regulatory network’s response to COVID-19.

The report is available in two formats:

  • Digital version: view online for an interactive timeline of EMA’s main activities in 2021 plus visuals and audio-visual materials exploring topics in depth
  • PDF version: downloadable, printable format with further figures and statistics on EMA's regulatory procedures and activities

EMA’s annual reports provide an overview of EMA’s work together with the European medicines regulatory network. They contain:

  • key achievements in protecting and promoting public and animal health in the EU;
  • reflections by EMA staff and its partners and stakeholders on topics of major interest in medicine and health;
  • key figures, including core statistics that highlight the main outcomes of the Agency's activities and interesting trends and changes observed in recent years.

EMA publishes its annual reports in May / June following the year in question.

EMA also publishes information on the volume and outcome of centralised procedures for human and veterinary medicines. For further details, see Medicine evaluation figures.

EMA’s work programmes (now called programming documents) reflect the priorities and main focus areas of EMA and of the European medicines regulatory network for the corresponding period and describe objectives and planned activities. They cover:

  • human medicines evaluation activities, split into pre-authorisation, initial evaluation, post-authorisation, pharmacovigilance and referrals;
  • veterinary medicines evaluation activities, with a similar structure to the human medicines chapter;
  • horizontal activities that enable and support the evaluation of human and veterinary medicines. These include committee coordination, inspections, partner and stakeholder relationship management, and data management;
  • corporate governance and support activities, including finance, human resources and quality management.

2021

EMA's annual report 2021 is available in two formats:

  • Digital version: view online for an interactive timeline of EMA’s main activities in 2020 plus visuals and audiovisual materials exploring topics in depth
  • PDF version: downloadable, printable format with further figures and statistics on EMA's regulatory procedures and activities.

2020

EMA's annual report 2020 is available in two formats:

  • Digital version: view online for an interactive timeline of EMA’s main activities in 2020 plus visuals exploring topics in depth
  • PDF version: downloadable, printable format with further figures and statistics on EMA's regulatory procedures and activities.

2019

EMA's annual report 2019 is available in two formats:

  • Digital version with an interactive timeline of EMA's main activities in 2019 and key figures for the year;
  • PDF version: downloadable, printable format with further figures and statistics on EMA's regulatory procedures and activities.

2016

2015

2013

2012

2011

2010

2009

2008

2007

2006

2005

1995-2004

Topics

How useful was this page?

Add your rating
Average
3 ratings
1 rating